Global Oncolytic Viral Drugs Supply, Demand and Key Producers, 2023-2029
The global Oncolytic Viral Drugs market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Oncolytic virus (OV) is a type of virus that can specifically replicate and cause cancer cell apoptosis while sparing normal tissue from being destroyed. Oncolytic virus therapy is a promising cancer treatment method. OVs can be divided into 2 main categories: natural viruses and genetically modified viruses. Naturally occurring OVs include reovirus, Newcastle disease virus (NDV), enterovirus and measles virus (MV), etc., and most OVs have been genetically modified to increase the tropism of the virus to tumor cells and improve virus selection. sexual replication and lytic potential, and enhance host anti-tumor immunity.
This report studies the global Oncolytic Viral Drugs production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Oncolytic Viral Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Oncolytic Viral Drugs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Oncolytic Viral Drugs total production and demand, 2018-2029, (K Units)
Global Oncolytic Viral Drugs total production value, 2018-2029, (USD Million)
Global Oncolytic Viral Drugs production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Oncolytic Viral Drugs consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Oncolytic Viral Drugs domestic production, consumption, key domestic manufacturers and share
Global Oncolytic Viral Drugs production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Oncolytic Viral Drugs production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Oncolytic Viral Drugs production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global Oncolytic Viral Drugs market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Amgen, Inc., Daiichi Sankyo Co., Ltd., Rigvir Holding and Shanghai Pharma Sunway Biotech, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Oncolytic Viral Drugs market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Oncolytic Viral Drugs Market, By Region:
1. How big is the global Oncolytic Viral Drugs market?
2. What is the demand of the global Oncolytic Viral Drugs market?
3. What is the year over year growth of the global Oncolytic Viral Drugs market?
4. What is the production and production value of the global Oncolytic Viral Drugs market?
5. Who are the key producers in the global Oncolytic Viral Drugs market?
Oncolytic virus (OV) is a type of virus that can specifically replicate and cause cancer cell apoptosis while sparing normal tissue from being destroyed. Oncolytic virus therapy is a promising cancer treatment method. OVs can be divided into 2 main categories: natural viruses and genetically modified viruses. Naturally occurring OVs include reovirus, Newcastle disease virus (NDV), enterovirus and measles virus (MV), etc., and most OVs have been genetically modified to increase the tropism of the virus to tumor cells and improve virus selection. sexual replication and lytic potential, and enhance host anti-tumor immunity.
This report studies the global Oncolytic Viral Drugs production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Oncolytic Viral Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Oncolytic Viral Drugs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Oncolytic Viral Drugs total production and demand, 2018-2029, (K Units)
Global Oncolytic Viral Drugs total production value, 2018-2029, (USD Million)
Global Oncolytic Viral Drugs production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Oncolytic Viral Drugs consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Oncolytic Viral Drugs domestic production, consumption, key domestic manufacturers and share
Global Oncolytic Viral Drugs production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Oncolytic Viral Drugs production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Oncolytic Viral Drugs production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global Oncolytic Viral Drugs market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Amgen, Inc., Daiichi Sankyo Co., Ltd., Rigvir Holding and Shanghai Pharma Sunway Biotech, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Oncolytic Viral Drugs market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Oncolytic Viral Drugs Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Natural Virus
- Genetically Modified Virus
- Nasopharyngeal Cancer
- Melanoma
- Glioma
- Other
- Amgen, Inc.
- Daiichi Sankyo Co., Ltd.
- Rigvir Holding
- Shanghai Pharma Sunway Biotech
1. How big is the global Oncolytic Viral Drugs market?
2. What is the demand of the global Oncolytic Viral Drugs market?
3. What is the year over year growth of the global Oncolytic Viral Drugs market?
4. What is the production and production value of the global Oncolytic Viral Drugs market?
5. Who are the key producers in the global Oncolytic Viral Drugs market?
1 SUPPLY SUMMARY
1.1 Oncolytic Viral Drugs Introduction
1.2 World Oncolytic Viral Drugs Supply & Forecast
1.2.1 World Oncolytic Viral Drugs Production Value (2018 & 2022 & 2029)
1.2.2 World Oncolytic Viral Drugs Production (2018-2029)
1.2.3 World Oncolytic Viral Drugs Pricing Trends (2018-2029)
1.3 World Oncolytic Viral Drugs Production by Region (Based on Production Site)
1.3.1 World Oncolytic Viral Drugs Production Value by Region (2018-2029)
1.3.2 World Oncolytic Viral Drugs Production by Region (2018-2029)
1.3.3 World Oncolytic Viral Drugs Average Price by Region (2018-2029)
1.3.4 North America Oncolytic Viral Drugs Production (2018-2029)
1.3.5 Europe Oncolytic Viral Drugs Production (2018-2029)
1.3.6 China Oncolytic Viral Drugs Production (2018-2029)
1.3.7 Japan Oncolytic Viral Drugs Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Oncolytic Viral Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Oncolytic Viral Drugs Major Market Trends
2 DEMAND SUMMARY
2.1 World Oncolytic Viral Drugs Demand (2018-2029)
2.2 World Oncolytic Viral Drugs Consumption by Region
2.2.1 World Oncolytic Viral Drugs Consumption by Region (2018-2023)
2.2.2 World Oncolytic Viral Drugs Consumption Forecast by Region (2024-2029)
2.3 United States Oncolytic Viral Drugs Consumption (2018-2029)
2.4 China Oncolytic Viral Drugs Consumption (2018-2029)
2.5 Europe Oncolytic Viral Drugs Consumption (2018-2029)
2.6 Japan Oncolytic Viral Drugs Consumption (2018-2029)
2.7 South Korea Oncolytic Viral Drugs Consumption (2018-2029)
2.8 ASEAN Oncolytic Viral Drugs Consumption (2018-2029)
2.9 India Oncolytic Viral Drugs Consumption (2018-2029)
3 WORLD ONCOLYTIC VIRAL DRUGS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Oncolytic Viral Drugs Production Value by Manufacturer (2018-2023)
3.2 World Oncolytic Viral Drugs Production by Manufacturer (2018-2023)
3.3 World Oncolytic Viral Drugs Average Price by Manufacturer (2018-2023)
3.4 Oncolytic Viral Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Oncolytic Viral Drugs Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Oncolytic Viral Drugs in 2022
3.5.3 Global Concentration Ratios (CR8) for Oncolytic Viral Drugs in 2022
3.6 Oncolytic Viral Drugs Market: Overall Company Footprint Analysis
3.6.1 Oncolytic Viral Drugs Market: Region Footprint
3.6.2 Oncolytic Viral Drugs Market: Company Product Type Footprint
3.6.3 Oncolytic Viral Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Oncolytic Viral Drugs Production Value Comparison
4.1.1 United States VS China: Oncolytic Viral Drugs Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Oncolytic Viral Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Oncolytic Viral Drugs Production Comparison
4.2.1 United States VS China: Oncolytic Viral Drugs Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Oncolytic Viral Drugs Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Oncolytic Viral Drugs Consumption Comparison
4.3.1 United States VS China: Oncolytic Viral Drugs Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Oncolytic Viral Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Oncolytic Viral Drugs Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Oncolytic Viral Drugs Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Oncolytic Viral Drugs Production Value (2018-2023)
4.4.3 United States Based Manufacturers Oncolytic Viral Drugs Production (2018-2023)
4.5 China Based Oncolytic Viral Drugs Manufacturers and Market Share
4.5.1 China Based Oncolytic Viral Drugs Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Oncolytic Viral Drugs Production Value (2018-2023)
4.5.3 China Based Manufacturers Oncolytic Viral Drugs Production (2018-2023)
4.6 Rest of World Based Oncolytic Viral Drugs Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Oncolytic Viral Drugs Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Oncolytic Viral Drugs Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Oncolytic Viral Drugs Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Oncolytic Viral Drugs Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Natural Virus
5.2.2 Genetically Modified Virus
5.3 Market Segment by Type
5.3.1 World Oncolytic Viral Drugs Production by Type (2018-2029)
5.3.2 World Oncolytic Viral Drugs Production Value by Type (2018-2029)
5.3.3 World Oncolytic Viral Drugs Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Oncolytic Viral Drugs Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Nasopharyngeal Cancer
6.2.2 Melanoma
6.2.3 Glioma
6.2.4 Other
6.3 Market Segment by Application
6.3.1 World Oncolytic Viral Drugs Production by Application (2018-2029)
6.3.2 World Oncolytic Viral Drugs Production Value by Application (2018-2029)
6.3.3 World Oncolytic Viral Drugs Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Amgen, Inc.
7.1.1 Amgen, Inc. Details
7.1.2 Amgen, Inc. Major Business
7.1.3 Amgen, Inc. Oncolytic Viral Drugs Product and Services
7.1.4 Amgen, Inc. Oncolytic Viral Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Amgen, Inc. Recent Developments/Updates
7.1.6 Amgen, Inc. Competitive Strengths & Weaknesses
7.2 Daiichi Sankyo Co., Ltd.
7.2.1 Daiichi Sankyo Co., Ltd. Details
7.2.2 Daiichi Sankyo Co., Ltd. Major Business
7.2.3 Daiichi Sankyo Co., Ltd. Oncolytic Viral Drugs Product and Services
7.2.4 Daiichi Sankyo Co., Ltd. Oncolytic Viral Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Daiichi Sankyo Co., Ltd. Recent Developments/Updates
7.2.6 Daiichi Sankyo Co., Ltd. Competitive Strengths & Weaknesses
7.3 Rigvir Holding
7.3.1 Rigvir Holding Details
7.3.2 Rigvir Holding Major Business
7.3.3 Rigvir Holding Oncolytic Viral Drugs Product and Services
7.3.4 Rigvir Holding Oncolytic Viral Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Rigvir Holding Recent Developments/Updates
7.3.6 Rigvir Holding Competitive Strengths & Weaknesses
7.4 Shanghai Pharma Sunway Biotech
7.4.1 Shanghai Pharma Sunway Biotech Details
7.4.2 Shanghai Pharma Sunway Biotech Major Business
7.4.3 Shanghai Pharma Sunway Biotech Oncolytic Viral Drugs Product and Services
7.4.4 Shanghai Pharma Sunway Biotech Oncolytic Viral Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Shanghai Pharma Sunway Biotech Recent Developments/Updates
7.4.6 Shanghai Pharma Sunway Biotech Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Oncolytic Viral Drugs Industry Chain
8.2 Oncolytic Viral Drugs Upstream Analysis
8.2.1 Oncolytic Viral Drugs Core Raw Materials
8.2.2 Main Manufacturers of Oncolytic Viral Drugs Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Oncolytic Viral Drugs Production Mode
8.6 Oncolytic Viral Drugs Procurement Model
8.7 Oncolytic Viral Drugs Industry Sales Model and Sales Channels
8.7.1 Oncolytic Viral Drugs Sales Model
8.7.2 Oncolytic Viral Drugs Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Oncolytic Viral Drugs Introduction
1.2 World Oncolytic Viral Drugs Supply & Forecast
1.2.1 World Oncolytic Viral Drugs Production Value (2018 & 2022 & 2029)
1.2.2 World Oncolytic Viral Drugs Production (2018-2029)
1.2.3 World Oncolytic Viral Drugs Pricing Trends (2018-2029)
1.3 World Oncolytic Viral Drugs Production by Region (Based on Production Site)
1.3.1 World Oncolytic Viral Drugs Production Value by Region (2018-2029)
1.3.2 World Oncolytic Viral Drugs Production by Region (2018-2029)
1.3.3 World Oncolytic Viral Drugs Average Price by Region (2018-2029)
1.3.4 North America Oncolytic Viral Drugs Production (2018-2029)
1.3.5 Europe Oncolytic Viral Drugs Production (2018-2029)
1.3.6 China Oncolytic Viral Drugs Production (2018-2029)
1.3.7 Japan Oncolytic Viral Drugs Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Oncolytic Viral Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Oncolytic Viral Drugs Major Market Trends
2 DEMAND SUMMARY
2.1 World Oncolytic Viral Drugs Demand (2018-2029)
2.2 World Oncolytic Viral Drugs Consumption by Region
2.2.1 World Oncolytic Viral Drugs Consumption by Region (2018-2023)
2.2.2 World Oncolytic Viral Drugs Consumption Forecast by Region (2024-2029)
2.3 United States Oncolytic Viral Drugs Consumption (2018-2029)
2.4 China Oncolytic Viral Drugs Consumption (2018-2029)
2.5 Europe Oncolytic Viral Drugs Consumption (2018-2029)
2.6 Japan Oncolytic Viral Drugs Consumption (2018-2029)
2.7 South Korea Oncolytic Viral Drugs Consumption (2018-2029)
2.8 ASEAN Oncolytic Viral Drugs Consumption (2018-2029)
2.9 India Oncolytic Viral Drugs Consumption (2018-2029)
3 WORLD ONCOLYTIC VIRAL DRUGS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Oncolytic Viral Drugs Production Value by Manufacturer (2018-2023)
3.2 World Oncolytic Viral Drugs Production by Manufacturer (2018-2023)
3.3 World Oncolytic Viral Drugs Average Price by Manufacturer (2018-2023)
3.4 Oncolytic Viral Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Oncolytic Viral Drugs Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Oncolytic Viral Drugs in 2022
3.5.3 Global Concentration Ratios (CR8) for Oncolytic Viral Drugs in 2022
3.6 Oncolytic Viral Drugs Market: Overall Company Footprint Analysis
3.6.1 Oncolytic Viral Drugs Market: Region Footprint
3.6.2 Oncolytic Viral Drugs Market: Company Product Type Footprint
3.6.3 Oncolytic Viral Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Oncolytic Viral Drugs Production Value Comparison
4.1.1 United States VS China: Oncolytic Viral Drugs Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Oncolytic Viral Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Oncolytic Viral Drugs Production Comparison
4.2.1 United States VS China: Oncolytic Viral Drugs Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Oncolytic Viral Drugs Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Oncolytic Viral Drugs Consumption Comparison
4.3.1 United States VS China: Oncolytic Viral Drugs Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Oncolytic Viral Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Oncolytic Viral Drugs Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Oncolytic Viral Drugs Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Oncolytic Viral Drugs Production Value (2018-2023)
4.4.3 United States Based Manufacturers Oncolytic Viral Drugs Production (2018-2023)
4.5 China Based Oncolytic Viral Drugs Manufacturers and Market Share
4.5.1 China Based Oncolytic Viral Drugs Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Oncolytic Viral Drugs Production Value (2018-2023)
4.5.3 China Based Manufacturers Oncolytic Viral Drugs Production (2018-2023)
4.6 Rest of World Based Oncolytic Viral Drugs Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Oncolytic Viral Drugs Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Oncolytic Viral Drugs Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Oncolytic Viral Drugs Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Oncolytic Viral Drugs Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Natural Virus
5.2.2 Genetically Modified Virus
5.3 Market Segment by Type
5.3.1 World Oncolytic Viral Drugs Production by Type (2018-2029)
5.3.2 World Oncolytic Viral Drugs Production Value by Type (2018-2029)
5.3.3 World Oncolytic Viral Drugs Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Oncolytic Viral Drugs Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Nasopharyngeal Cancer
6.2.2 Melanoma
6.2.3 Glioma
6.2.4 Other
6.3 Market Segment by Application
6.3.1 World Oncolytic Viral Drugs Production by Application (2018-2029)
6.3.2 World Oncolytic Viral Drugs Production Value by Application (2018-2029)
6.3.3 World Oncolytic Viral Drugs Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Amgen, Inc.
7.1.1 Amgen, Inc. Details
7.1.2 Amgen, Inc. Major Business
7.1.3 Amgen, Inc. Oncolytic Viral Drugs Product and Services
7.1.4 Amgen, Inc. Oncolytic Viral Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Amgen, Inc. Recent Developments/Updates
7.1.6 Amgen, Inc. Competitive Strengths & Weaknesses
7.2 Daiichi Sankyo Co., Ltd.
7.2.1 Daiichi Sankyo Co., Ltd. Details
7.2.2 Daiichi Sankyo Co., Ltd. Major Business
7.2.3 Daiichi Sankyo Co., Ltd. Oncolytic Viral Drugs Product and Services
7.2.4 Daiichi Sankyo Co., Ltd. Oncolytic Viral Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Daiichi Sankyo Co., Ltd. Recent Developments/Updates
7.2.6 Daiichi Sankyo Co., Ltd. Competitive Strengths & Weaknesses
7.3 Rigvir Holding
7.3.1 Rigvir Holding Details
7.3.2 Rigvir Holding Major Business
7.3.3 Rigvir Holding Oncolytic Viral Drugs Product and Services
7.3.4 Rigvir Holding Oncolytic Viral Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Rigvir Holding Recent Developments/Updates
7.3.6 Rigvir Holding Competitive Strengths & Weaknesses
7.4 Shanghai Pharma Sunway Biotech
7.4.1 Shanghai Pharma Sunway Biotech Details
7.4.2 Shanghai Pharma Sunway Biotech Major Business
7.4.3 Shanghai Pharma Sunway Biotech Oncolytic Viral Drugs Product and Services
7.4.4 Shanghai Pharma Sunway Biotech Oncolytic Viral Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Shanghai Pharma Sunway Biotech Recent Developments/Updates
7.4.6 Shanghai Pharma Sunway Biotech Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Oncolytic Viral Drugs Industry Chain
8.2 Oncolytic Viral Drugs Upstream Analysis
8.2.1 Oncolytic Viral Drugs Core Raw Materials
8.2.2 Main Manufacturers of Oncolytic Viral Drugs Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Oncolytic Viral Drugs Production Mode
8.6 Oncolytic Viral Drugs Procurement Model
8.7 Oncolytic Viral Drugs Industry Sales Model and Sales Channels
8.7.1 Oncolytic Viral Drugs Sales Model
8.7.2 Oncolytic Viral Drugs Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Oncolytic Viral Drugs Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Oncolytic Viral Drugs Production Value by Region (2018-2023) & (USD Million)
Table 3. World Oncolytic Viral Drugs Production Value by Region (2024-2029) & (USD Million)
Table 4. World Oncolytic Viral Drugs Production Value Market Share by Region (2018-2023)
Table 5. World Oncolytic Viral Drugs Production Value Market Share by Region (2024-2029)
Table 6. World Oncolytic Viral Drugs Production by Region (2018-2023) & (K Units)
Table 7. World Oncolytic Viral Drugs Production by Region (2024-2029) & (K Units)
Table 8. World Oncolytic Viral Drugs Production Market Share by Region (2018-2023)
Table 9. World Oncolytic Viral Drugs Production Market Share by Region (2024-2029)
Table 10. World Oncolytic Viral Drugs Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Oncolytic Viral Drugs Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Oncolytic Viral Drugs Major Market Trends
Table 13. World Oncolytic Viral Drugs Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Oncolytic Viral Drugs Consumption by Region (2018-2023) & (K Units)
Table 15. World Oncolytic Viral Drugs Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Oncolytic Viral Drugs Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Oncolytic Viral Drugs Producers in 2022
Table 18. World Oncolytic Viral Drugs Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Oncolytic Viral Drugs Producers in 2022
Table 20. World Oncolytic Viral Drugs Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Oncolytic Viral Drugs Company Evaluation Quadrant
Table 22. World Oncolytic Viral Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Oncolytic Viral Drugs Production Site of Key Manufacturer
Table 24. Oncolytic Viral Drugs Market: Company Product Type Footprint
Table 25. Oncolytic Viral Drugs Market: Company Product Application Footprint
Table 26. Oncolytic Viral Drugs Competitive Factors
Table 27. Oncolytic Viral Drugs New Entrant and Capacity Expansion Plans
Table 28. Oncolytic Viral Drugs Mergers & Acquisitions Activity
Table 29. United States VS China Oncolytic Viral Drugs Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Oncolytic Viral Drugs Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Oncolytic Viral Drugs Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Oncolytic Viral Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Oncolytic Viral Drugs Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Oncolytic Viral Drugs Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Oncolytic Viral Drugs Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Oncolytic Viral Drugs Production Market Share (2018-2023)
Table 37. China Based Oncolytic Viral Drugs Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Oncolytic Viral Drugs Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Oncolytic Viral Drugs Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Oncolytic Viral Drugs Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Oncolytic Viral Drugs Production Market Share (2018-2023)
Table 42. Rest of World Based Oncolytic Viral Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Oncolytic Viral Drugs Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Oncolytic Viral Drugs Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Oncolytic Viral Drugs Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Oncolytic Viral Drugs Production Market Share (2018-2023)
Table 47. World Oncolytic Viral Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Oncolytic Viral Drugs Production by Type (2018-2023) & (K Units)
Table 49. World Oncolytic Viral Drugs Production by Type (2024-2029) & (K Units)
Table 50. World Oncolytic Viral Drugs Production Value by Type (2018-2023) & (USD Million)
Table 51. World Oncolytic Viral Drugs Production Value by Type (2024-2029) & (USD Million)
Table 52. World Oncolytic Viral Drugs Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Oncolytic Viral Drugs Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Oncolytic Viral Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Oncolytic Viral Drugs Production by Application (2018-2023) & (K Units)
Table 56. World Oncolytic Viral Drugs Production by Application (2024-2029) & (K Units)
Table 57. World Oncolytic Viral Drugs Production Value by Application (2018-2023) & (USD Million)
Table 58. World Oncolytic Viral Drugs Production Value by Application (2024-2029) & (USD Million)
Table 59. World Oncolytic Viral Drugs Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Oncolytic Viral Drugs Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Amgen, Inc. Basic Information, Manufacturing Base and Competitors
Table 62. Amgen, Inc. Major Business
Table 63. Amgen, Inc. Oncolytic Viral Drugs Product and Services
Table 64. Amgen, Inc. Oncolytic Viral Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Amgen, Inc. Recent Developments/Updates
Table 66. Amgen, Inc. Competitive Strengths & Weaknesses
Table 67. Daiichi Sankyo Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 68. Daiichi Sankyo Co., Ltd. Major Business
Table 69. Daiichi Sankyo Co., Ltd. Oncolytic Viral Drugs Product and Services
Table 70. Daiichi Sankyo Co., Ltd. Oncolytic Viral Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Daiichi Sankyo Co., Ltd. Recent Developments/Updates
Table 72. Daiichi Sankyo Co., Ltd. Competitive Strengths & Weaknesses
Table 73. Rigvir Holding Basic Information, Manufacturing Base and Competitors
Table 74. Rigvir Holding Major Business
Table 75. Rigvir Holding Oncolytic Viral Drugs Product and Services
Table 76. Rigvir Holding Oncolytic Viral Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Rigvir Holding Recent Developments/Updates
Table 78. Shanghai Pharma Sunway Biotech Basic Information, Manufacturing Base and Competitors
Table 79. Shanghai Pharma Sunway Biotech Major Business
Table 80. Shanghai Pharma Sunway Biotech Oncolytic Viral Drugs Product and Services
Table 81. Shanghai Pharma Sunway Biotech Oncolytic Viral Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Global Key Players of Oncolytic Viral Drugs Upstream (Raw Materials)
Table 83. Oncolytic Viral Drugs Typical Customers
Table 84. Oncolytic Viral Drugs Typical Distributors
LIST OF FIGURE
Figure 1. Oncolytic Viral Drugs Picture
Figure 2. World Oncolytic Viral Drugs Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Oncolytic Viral Drugs Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Oncolytic Viral Drugs Production (2018-2029) & (K Units)
Figure 5. World Oncolytic Viral Drugs Average Price (2018-2029) & (US$/Unit)
Figure 6. World Oncolytic Viral Drugs Production Value Market Share by Region (2018-2029)
Figure 7. World Oncolytic Viral Drugs Production Market Share by Region (2018-2029)
Figure 8. North America Oncolytic Viral Drugs Production (2018-2029) & (K Units)
Figure 9. Europe Oncolytic Viral Drugs Production (2018-2029) & (K Units)
Figure 10. China Oncolytic Viral Drugs Production (2018-2029) & (K Units)
Figure 11. Japan Oncolytic Viral Drugs Production (2018-2029) & (K Units)
Figure 12. Oncolytic Viral Drugs Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Oncolytic Viral Drugs Consumption (2018-2029) & (K Units)
Figure 15. World Oncolytic Viral Drugs Consumption Market Share by Region (2018-2029)
Figure 16. United States Oncolytic Viral Drugs Consumption (2018-2029) & (K Units)
Figure 17. China Oncolytic Viral Drugs Consumption (2018-2029) & (K Units)
Figure 18. Europe Oncolytic Viral Drugs Consumption (2018-2029) & (K Units)
Figure 19. Japan Oncolytic Viral Drugs Consumption (2018-2029) & (K Units)
Figure 20. South Korea Oncolytic Viral Drugs Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Oncolytic Viral Drugs Consumption (2018-2029) & (K Units)
Figure 22. India Oncolytic Viral Drugs Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Oncolytic Viral Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Oncolytic Viral Drugs Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Oncolytic Viral Drugs Markets in 2022
Figure 26. United States VS China: Oncolytic Viral Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Oncolytic Viral Drugs Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Oncolytic Viral Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Oncolytic Viral Drugs Production Market Share 2022
Figure 30. China Based Manufacturers Oncolytic Viral Drugs Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Oncolytic Viral Drugs Production Market Share 2022
Figure 32. World Oncolytic Viral Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Oncolytic Viral Drugs Production Value Market Share by Type in 2022
Figure 34. Natural Virus
Figure 35. Genetically Modified Virus
Figure 36. World Oncolytic Viral Drugs Production Market Share by Type (2018-2029)
Figure 37. World Oncolytic Viral Drugs Production Value Market Share by Type (2018-2029)
Figure 38. World Oncolytic Viral Drugs Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Oncolytic Viral Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Oncolytic Viral Drugs Production Value Market Share by Application in 2022
Figure 41. Nasopharyngeal Cancer
Figure 42. Melanoma
Figure 43. Glioma
Figure 44. Other
Figure 45. World Oncolytic Viral Drugs Production Market Share by Application (2018-2029)
Figure 46. World Oncolytic Viral Drugs Production Value Market Share by Application (2018-2029)
Figure 47. World Oncolytic Viral Drugs Average Price by Application (2018-2029) & (US$/Unit)
Figure 48. Oncolytic Viral Drugs Industry Chain
Figure 49. Oncolytic Viral Drugs Procurement Model
Figure 50. Oncolytic Viral Drugs Sales Model
Figure 51. Oncolytic Viral Drugs Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
Table 1. World Oncolytic Viral Drugs Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Oncolytic Viral Drugs Production Value by Region (2018-2023) & (USD Million)
Table 3. World Oncolytic Viral Drugs Production Value by Region (2024-2029) & (USD Million)
Table 4. World Oncolytic Viral Drugs Production Value Market Share by Region (2018-2023)
Table 5. World Oncolytic Viral Drugs Production Value Market Share by Region (2024-2029)
Table 6. World Oncolytic Viral Drugs Production by Region (2018-2023) & (K Units)
Table 7. World Oncolytic Viral Drugs Production by Region (2024-2029) & (K Units)
Table 8. World Oncolytic Viral Drugs Production Market Share by Region (2018-2023)
Table 9. World Oncolytic Viral Drugs Production Market Share by Region (2024-2029)
Table 10. World Oncolytic Viral Drugs Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Oncolytic Viral Drugs Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Oncolytic Viral Drugs Major Market Trends
Table 13. World Oncolytic Viral Drugs Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Oncolytic Viral Drugs Consumption by Region (2018-2023) & (K Units)
Table 15. World Oncolytic Viral Drugs Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Oncolytic Viral Drugs Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Oncolytic Viral Drugs Producers in 2022
Table 18. World Oncolytic Viral Drugs Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Oncolytic Viral Drugs Producers in 2022
Table 20. World Oncolytic Viral Drugs Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Oncolytic Viral Drugs Company Evaluation Quadrant
Table 22. World Oncolytic Viral Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Oncolytic Viral Drugs Production Site of Key Manufacturer
Table 24. Oncolytic Viral Drugs Market: Company Product Type Footprint
Table 25. Oncolytic Viral Drugs Market: Company Product Application Footprint
Table 26. Oncolytic Viral Drugs Competitive Factors
Table 27. Oncolytic Viral Drugs New Entrant and Capacity Expansion Plans
Table 28. Oncolytic Viral Drugs Mergers & Acquisitions Activity
Table 29. United States VS China Oncolytic Viral Drugs Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Oncolytic Viral Drugs Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Oncolytic Viral Drugs Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Oncolytic Viral Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Oncolytic Viral Drugs Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Oncolytic Viral Drugs Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Oncolytic Viral Drugs Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Oncolytic Viral Drugs Production Market Share (2018-2023)
Table 37. China Based Oncolytic Viral Drugs Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Oncolytic Viral Drugs Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Oncolytic Viral Drugs Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Oncolytic Viral Drugs Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Oncolytic Viral Drugs Production Market Share (2018-2023)
Table 42. Rest of World Based Oncolytic Viral Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Oncolytic Viral Drugs Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Oncolytic Viral Drugs Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Oncolytic Viral Drugs Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Oncolytic Viral Drugs Production Market Share (2018-2023)
Table 47. World Oncolytic Viral Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Oncolytic Viral Drugs Production by Type (2018-2023) & (K Units)
Table 49. World Oncolytic Viral Drugs Production by Type (2024-2029) & (K Units)
Table 50. World Oncolytic Viral Drugs Production Value by Type (2018-2023) & (USD Million)
Table 51. World Oncolytic Viral Drugs Production Value by Type (2024-2029) & (USD Million)
Table 52. World Oncolytic Viral Drugs Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Oncolytic Viral Drugs Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Oncolytic Viral Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Oncolytic Viral Drugs Production by Application (2018-2023) & (K Units)
Table 56. World Oncolytic Viral Drugs Production by Application (2024-2029) & (K Units)
Table 57. World Oncolytic Viral Drugs Production Value by Application (2018-2023) & (USD Million)
Table 58. World Oncolytic Viral Drugs Production Value by Application (2024-2029) & (USD Million)
Table 59. World Oncolytic Viral Drugs Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Oncolytic Viral Drugs Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Amgen, Inc. Basic Information, Manufacturing Base and Competitors
Table 62. Amgen, Inc. Major Business
Table 63. Amgen, Inc. Oncolytic Viral Drugs Product and Services
Table 64. Amgen, Inc. Oncolytic Viral Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Amgen, Inc. Recent Developments/Updates
Table 66. Amgen, Inc. Competitive Strengths & Weaknesses
Table 67. Daiichi Sankyo Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 68. Daiichi Sankyo Co., Ltd. Major Business
Table 69. Daiichi Sankyo Co., Ltd. Oncolytic Viral Drugs Product and Services
Table 70. Daiichi Sankyo Co., Ltd. Oncolytic Viral Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Daiichi Sankyo Co., Ltd. Recent Developments/Updates
Table 72. Daiichi Sankyo Co., Ltd. Competitive Strengths & Weaknesses
Table 73. Rigvir Holding Basic Information, Manufacturing Base and Competitors
Table 74. Rigvir Holding Major Business
Table 75. Rigvir Holding Oncolytic Viral Drugs Product and Services
Table 76. Rigvir Holding Oncolytic Viral Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Rigvir Holding Recent Developments/Updates
Table 78. Shanghai Pharma Sunway Biotech Basic Information, Manufacturing Base and Competitors
Table 79. Shanghai Pharma Sunway Biotech Major Business
Table 80. Shanghai Pharma Sunway Biotech Oncolytic Viral Drugs Product and Services
Table 81. Shanghai Pharma Sunway Biotech Oncolytic Viral Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Global Key Players of Oncolytic Viral Drugs Upstream (Raw Materials)
Table 83. Oncolytic Viral Drugs Typical Customers
Table 84. Oncolytic Viral Drugs Typical Distributors
LIST OF FIGURE
Figure 1. Oncolytic Viral Drugs Picture
Figure 2. World Oncolytic Viral Drugs Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Oncolytic Viral Drugs Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Oncolytic Viral Drugs Production (2018-2029) & (K Units)
Figure 5. World Oncolytic Viral Drugs Average Price (2018-2029) & (US$/Unit)
Figure 6. World Oncolytic Viral Drugs Production Value Market Share by Region (2018-2029)
Figure 7. World Oncolytic Viral Drugs Production Market Share by Region (2018-2029)
Figure 8. North America Oncolytic Viral Drugs Production (2018-2029) & (K Units)
Figure 9. Europe Oncolytic Viral Drugs Production (2018-2029) & (K Units)
Figure 10. China Oncolytic Viral Drugs Production (2018-2029) & (K Units)
Figure 11. Japan Oncolytic Viral Drugs Production (2018-2029) & (K Units)
Figure 12. Oncolytic Viral Drugs Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Oncolytic Viral Drugs Consumption (2018-2029) & (K Units)
Figure 15. World Oncolytic Viral Drugs Consumption Market Share by Region (2018-2029)
Figure 16. United States Oncolytic Viral Drugs Consumption (2018-2029) & (K Units)
Figure 17. China Oncolytic Viral Drugs Consumption (2018-2029) & (K Units)
Figure 18. Europe Oncolytic Viral Drugs Consumption (2018-2029) & (K Units)
Figure 19. Japan Oncolytic Viral Drugs Consumption (2018-2029) & (K Units)
Figure 20. South Korea Oncolytic Viral Drugs Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Oncolytic Viral Drugs Consumption (2018-2029) & (K Units)
Figure 22. India Oncolytic Viral Drugs Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Oncolytic Viral Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Oncolytic Viral Drugs Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Oncolytic Viral Drugs Markets in 2022
Figure 26. United States VS China: Oncolytic Viral Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Oncolytic Viral Drugs Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Oncolytic Viral Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Oncolytic Viral Drugs Production Market Share 2022
Figure 30. China Based Manufacturers Oncolytic Viral Drugs Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Oncolytic Viral Drugs Production Market Share 2022
Figure 32. World Oncolytic Viral Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Oncolytic Viral Drugs Production Value Market Share by Type in 2022
Figure 34. Natural Virus
Figure 35. Genetically Modified Virus
Figure 36. World Oncolytic Viral Drugs Production Market Share by Type (2018-2029)
Figure 37. World Oncolytic Viral Drugs Production Value Market Share by Type (2018-2029)
Figure 38. World Oncolytic Viral Drugs Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Oncolytic Viral Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Oncolytic Viral Drugs Production Value Market Share by Application in 2022
Figure 41. Nasopharyngeal Cancer
Figure 42. Melanoma
Figure 43. Glioma
Figure 44. Other
Figure 45. World Oncolytic Viral Drugs Production Market Share by Application (2018-2029)
Figure 46. World Oncolytic Viral Drugs Production Value Market Share by Application (2018-2029)
Figure 47. World Oncolytic Viral Drugs Average Price by Application (2018-2029) & (US$/Unit)
Figure 48. Oncolytic Viral Drugs Industry Chain
Figure 49. Oncolytic Viral Drugs Procurement Model
Figure 50. Oncolytic Viral Drugs Sales Model
Figure 51. Oncolytic Viral Drugs Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
